Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Stochastic synaptic plasticity underlying compulsion in a model of addiction.

Pascoli V, Hiver A, Van Zessen R, Loureiro M, Achargui R, Harada M, Flakowski J, Lüscher C.

Nature. 2018 Dec;564(7736):366-371. doi: 10.1038/s41586-018-0789-4. Epub 2018 Dec 19.

PMID:
30568192
2.

Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.

Pascoli V, Terrier J, Hiver A, Lüscher C.

Neuron. 2015 Dec 2;88(5):1054-1066. doi: 10.1016/j.neuron.2015.10.017. Epub 2015 Nov 12.

3.

Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies.

Dati G, Quattrini A, Bernasconi L, Malaguti MC, Antonsson B, Nicoletti F, Alliod C, Di Marco R, Sagot Y, Vitte PA, Hiver A, Greco B, Roach A, Zaratin PF.

J Neuroimmunol. 2007 Oct;190(1-2):8-17. Epub 2007 Aug 21.

PMID:
17714795
4.

Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia.

Hetz C, Vitte PA, Bombrun A, Rostovtseva TK, Montessuit S, Hiver A, Schwarz MK, Church DJ, Korsmeyer SJ, Martinou JC, Antonsson B.

J Biol Chem. 2005 Dec 30;280(52):42960-70. Epub 2005 Oct 11. Erratum in: J Biol Chem. 2012 Dec 28;287(53):44108.

5.

AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties.

Carboni S, Hiver A, Szyndralewiez C, Gaillard P, Gotteland JP, Vitte PA.

J Pharmacol Exp Ther. 2004 Jul;310(1):25-32. Epub 2004 Feb 26.

PMID:
14988419

Supplemental Content

Support Center